Literature DB >> 15932279

Optimized retroviral transduction protocol which preserves the primitive subpopulation of human hematopoietic cells.

Alex Tonks1, Amanda J Tonks, Lorna Pearn, Zulkhairi Mohamad, Alan K Burnett, Richard L Darley.   

Abstract

Though both low-speed centrifugation and the use of fibronectin (Retronectin) fragments increase gene transduction efficiency, they still do not overcome the adverse effects of the presence of virus-containing medium (VCM). In this study, we improved transduction efficiency of primitive human hematopoietic cells by optimizing the conditions for preadsorbing culture dishes with retrovirus using a centrifugation protocol allowing subsequent infection to be carried out in the absence of VCM. We also demonstrate that preadsorbing tissue culture plates with retrovirus is dependent on the volume of VCM used for preadsorption and the length of centrifugation and the type of plasticware used but not on the temperature of centrifugation (4-33 degrees C). Direct exposure of CD34+ target cells to VCM depletes the primitive CD34+CD38neg subpopulation by more than 30%, whereas the optimized VCM-free infection protocol targets this population with equivalent efficiency but had no detrimental effects on CD34+CD38neg frequency. In summary, we demonstrate a high-frequency transduction protocol which preserves the therapeutically relevant primitive subpopulation of human hematopoietic cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932279     DOI: 10.1021/bp0500314

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  8 in total

1.  Scaffold-Mediated Static Transduction of T Cells for CAR-T Cell Therapy.

Authors:  Pritha Agarwalla; Edikan A Ogunnaike; Sarah Ahn; Frances S Ligler; Gianpietro Dotti; Yevgeny Brudno
Journal:  Adv Healthc Mater       Date:  2020-06-11       Impact factor: 9.933

2.  Retroviral Transduction of T Cells and T Cell Precursors.

Authors:  Amie Simmons; José Alberola-Ila
Journal:  Methods Mol Biol       Date:  2016

3.  Protein Kinase C Epsilon Overexpression Is Associated With Poor Patient Outcomes in AML and Promotes Daunorubicin Resistance Through p-Glycoprotein-Mediated Drug Efflux.

Authors:  Rachael Nicholson; Ana Catarina Menezes; Aleksandra Azevedo; Adam Leckenby; Sara Davies; Claire Seedhouse; Amanda Gilkes; Steve Knapper; Alex Tonks; Richard L Darley
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

4.  Cord Blood-Derived Quiescent CD34+ Cells Are More Transcriptionally Matched to AML Blasts Than Cytokine-Induced Normal Human Hematopoietic CD34+ Cells.

Authors:  Richard L Darley; Alex Tonks; Chinmay Munje; Robert K Hills; Anthony Whetton; Alan K Burnett
Journal:  Gene Expr       Date:  2015

5.  Increased expression of RUNX3 inhibits normal human myeloid development.

Authors:  Ana Catarina Menezes; Rachel Jones; Alina Shrestha; Rachael Nicholson; Adam Leckenby; Aleksandra Azevedo; Sara Davies; Sarah Baker; Amanda F Gilkes; Richard L Darley; Alex Tonks
Journal:  Leukemia       Date:  2022-04-30       Impact factor: 12.883

6.  Overexpression of connexin 43 using a retroviral vector improves electrical coupling of skeletal myoblasts with cardiac myocytes in vitro.

Authors:  Oleg Tolmachov; Yu-Ling Ma; Michael Themis; Pravina Patel; Hilmar Spohr; Kenneth T Macleod; Nina D Ullrich; Yvonne Kienast; Charles Coutelle; Nicholas S Peters
Journal:  BMC Cardiovasc Disord       Date:  2006-06-06       Impact factor: 2.298

7.  An efficient large-scale retroviral transduction method involving preloading the vector into a RetroNectin-coated bag with low-temperature shaking.

Authors:  Katsuyuki Dodo; Hideto Chono; Naoki Saito; Yoshinori Tanaka; Kenichi Tahara; Ikuei Nukaya; Junichi Mineno
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

8.  RUNX3 overexpression inhibits normal human erythroid development.

Authors:  Ana Catarina Menezes; Christabel Dixon; Anna Scholz; Rachael Nicholson; Adam Leckenby; Aleksandra Azevedo; Sarah Baker; Amanda F Gilkes; Sara Davies; Richard L Darley; Alex Tonks
Journal:  Sci Rep       Date:  2022-01-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.